Popular on Rezul


Similar on Rezul

JPM 2026: System Health Launches with Breakthrough AI Platform to Tackle Global Health Challenges

Rezul News/10724300
Founder Adam Bly Available for Media Briefings and Interviews

NEW YORK - Rezul -- WHO
Adam Bly is Founder & CEO of System Health. He previously led data at Spotify.  Named a World Economic Forum Young Global Leader, Adam is a frequent speaker on the role of data and science in society, with lectures at the United Nations, MIT, NASA, and the National Academy of Sciences.

WHAT
System Health is releasing the System Clinical Graph, a knowledge and data platform that leverages AI with evidence-based biomedical literature, clinical guidelines, and real-world evidence to power clinical decision support. The platform delivers a system-level view of health—helping improve patient outcomes, strengthen prevention, and inform policy. Built by the team behind System, a Public Benefit Corporation focused on modeling the world as one interconnected system. System Health has partnered with leading healthcare institutions as early adopters, working together to deploy its platform across clinical and preventive use cases designed to tackle global health challenges.

More on Rezul News
WHEN
JP Morgan Healthcare Conference
January 12–15, 2026

WHERE
San Francisco
Meetings on site at the Westin St. Francis Hotel and Marriott Marquis or media outlet offices

WHY IT MATTERS
As AI adoption in healthcare accelerates, the need for rigor, transparency, and accountability has never been higher. With the U.S. Department of Health and Human Services issuing a new Request for Information (RFI) to accelerate the use of AI in clinical care, responsible AI adoption in health tech has become a top priority.

System Health is setting a new bar at this critical moment. The company recently announced a major validation milestone: System's Synthesize API achieved a perfect 100% score on the publicly available United States Medical Licensing Examination (USMLE). Unlike traditional large language models, Synthesize relies solely on verified biomedical evidence and System's patented graph architecture, delivering verifiable, guideline-based clinical answers with citations.

Together, this positions Adam Bly (https://www.adambly.com/bio) and System Health at the forefront of an AI-forward, evidence-driven approach to transforming healthcare and tackling global health challenges.

More on Rezul News
TOPICS ADAM BLY CAN DISCUSS
  • How System Health is redefining clinical decision support
  • How partners are using Synthesize API in real workflows
  • Why healthcare needs evidence-validated AI - not black-box LLMs
  • How systems thinking can improve diagnosis, prevention, and population health
  • Future trends for health tech innovation, AI governance, and tech philanthropy

Adam Bly is available for briefings, interviews, stand-ups, and coffee chats. If you are not attending JPM, Adam is available for pre-coverage opportunities and to discuss trending topics.

To schedule a meeting or request embargoed materials for pre-coverage, please contact Lelani Clark at lelani@themaybe.org or 646-389-4129

Media Contact
Lelani Clark
lelani@themaybe.org
646-389-4129


Source: System Inc.

Show All News | Report Violation

0 Comments

Latest on Rezul News